The role of staphylothrombin-mediated fibrin deposition in catheter-related staphylococcus aureus infections

Journal of Infectious Diseases

Volumn 208, Issue 1, 2013, Pages 92-100

  Vanassche, Thomas ^a   Peetermans, Marijke ^a   Van Aelst, Lucas N L ^a   Peetermans, Willy E ^b   Verhaegen, Jan ^c   Missiakas, Dominique M ^d   Schneewind, Olaf ^d   Hoylaerts, Marc F ^a   Verhamme, Peter ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Department of Internal Medicine ^*  (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

catheter infection; dabigatran; staphylocoagulase; Staphylococcus aureus; staphylothrombin; von Willebrand factor binding protein

Indexed keywords

ARGATROBAN; BINDING PROTEIN; COAGULASE; DABIGATRAN; DABIGATRAN ETEXILATE; ENOXAPARIN; FIBRIN; FIBRINOGEN; HIRUDIN; PLACEBO; PROTHROMBIN; STAPHYCOAGULASE; STAPHYLOTHROMBIN; THROMBIN; UNCLASSIFIED DRUG; VANCOMYCIN; VON WILLEBRAND FACTOR BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; BACTERIUM ADHERENCE; BACTERIUM MUTANT; CATHETER INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG EFFICACY; ENZYME RELEASE; FIBRIN DEPOSITION; IN VITRO STUDY; INTRAVENOUS CATHETER; JUGULAR VEIN; KIDNEY INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

CATHETER INFECTION; DABIGATRAN; STAPHYLOCOAGULASE; STAPHYLOCOCCUS AUREUS; STAPHYLOTHROMBIN; VON WILLEBRAND FACTOR-BINDING PROTEIN;

ANIMALS; BACTERIAL ADHESION; BACTERIAL LOAD; BENZIMIDAZOLES; BETA-ALANINE; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; COAGULASE; DISEASE MODELS, ANIMAL; FIBRIN; JUGULAR VEINS; MALE; MICE; MICE, INBRED BALB C; STAPHYLOCOCCAL INFECTIONS; THROMBIN;

EID: 84878529058     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit130     Document Type: Article

References (48)

1. O'Grady NP, Alexander M, Burns LA, et al. Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-Related Infections. Clin Infect Dis 2011; 52:1087-99.
2. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-601.
3. Wenzel RP, Edmond MB. Team-based prevention of catheter-related infections. N Engl J Med 2006; 355:2781-3.
4. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132:391-402.
5. Walz JM, Memtsoudis SG, Heard SO. Prevention of central venous catheter bloodstream infections. J Intensive Care Med 2010; 25: 131-8.
6. Katneni R, Hedayati SS. Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 2007; 3:256-66.
7. Kaye KS, Marchaim D, Chen TY, et al. Predictors of nosocomial bloodstream infections in older adults. J Am Geriatr Soc 2011; 59:622-7.
8. Raad I, Hachem R, Hanna H, et al. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis 2007; 26:549-56.
9. Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant 2006; 21:1024-31.
10. Vaudaux PE, Waldvogel FA, Morgenthaler JJ, Nydegger UE. Adsorption of fibronectin onto polymethylmethacrylate and promotion of Staphylococcus aureus adherence. Infect Immun 1984; 45:768-74.
11. Wolz C, Goerke C, Landmann R, Zimmerli W, Fluckiger U. Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection. Infect Immun 2002; 70:2758-62.
12. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351:1645-54.
13. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358:135-8.
14. Friedrich R, Panizzi P, Fuentes-Prior P, et al. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature 2003; 425:535-9.
15. Bjerketorp J, Jacobsson K, Frykberg L. The von Willebrand factorbinding protein (vWbp) of Staphylococcus aureus is a coagulase. FEMS Microbiol Lett 2004; 234:309-14.
16. Kroh HK, Panizzi P, Bock PE. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc Natl Acad Sci U S A 2009; 106:7786-91.
17. Hijikata-Okunomiya A, Kataoka N. Argatroban inhibits staphylothrombin. J Thromb Haemost 2003; 1:2060-1.
18. Vanassche T, Verhaegen J, Peetermans WE, Hoylaerts MF, Verhamme P. Dabigatran inhibits Staphylococcus aureus coagulase activity. J Clin Microbiol 2010; 48:4248-50.
19. Vanassche T, Verhaegen J, Peetermans WE, et al. Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. J Thromb Haemost 2011; 9:2436-46.
20. Cheng AG, DeDent AC, Schneewind O, Missiakas D. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol 2011; 19:225-32.
21. Cheng AG, McAdow M, Kim HK, Bae T, Missiakas DM, Schneewind O. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog 2010; 6:e1001036.
22. Duthie ES, Lorenz LL. Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol 1952; 6:95-107.
23. Shahrooei M, Hira V, Khodaparast L, et al. Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation. Infect Immun. 2012. 80:3660-8.
24. Bogatkevich GS, Ludwicka-Bradley A, Nietert PJ, Akter T, van Ryn J, Silver RM. Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum 2011; 63:1416-25.
25. Loeb L. The influence of certain bacteria on the coagulation of the blood. J Med Res 1903; 10:407-19.
26. Moreillon P, Entenza JM, Francioli P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995; 63:4738-43.
27. Sawai T, Tomono K, Yanagihara K, et al. Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads. Infect Immun 1997; 65:466-71.
28. Yanagihara K, Tashiro M, Fukuda Y, et al. Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo. J Antimicrob Chemother 2006; 57:122-6.
29. McAdow M, Dedent AC, Emolo C, et al. Coagulases as determinants of protective immune responses against Staphylococcus aureus. Infect Immun 2012. 80:3389-98.
30. McAdow M, Kim HK, Dedent AC, Hendrickx AP, Schneewind O, Missiakas DM. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog 2011; 7:e1002307.
31. Vanassche T, Kauskot A, Verhaegen J, et al. Fibrin formation by staphylothrombin facilitates Staphylococcus aureus-induced platelet aggregation. Thromb Haemost 2012; 107:1107-21.
32. Costerton JW. Introduction to biofilm. Int J Antimicrob Agents 1999; 11:217-21; discussion 37-9.
33. O'Gara JP. Ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 2007; 270:179-88.
34. Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2011; 2:445-59.
35. Fluckiger U, Ulrich M, Steinhuber A, et al. Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect Immun 2005; 73:1811-9.
36. Cramton SE, Ulrich M, Gotz F, Doring G. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun 2001; 69: 4079-85.
37. O'Neill E, Pozzi C, Houston P, et al. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol 2007; 45:1379-88.
38. Fitzpatrick F, Humphreys H, O'Gara JP. Environmental regulation of biofilm development in methicillin-resistant and methicillinsusceptible Staphylococcus aureus clinical isolates. J Hosp Infect 2006; 62:120-2.
39. Fitzpatrick F, Humphreys H, O'Gara JP. Evidence for icaADBC-independent biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates. J Clin Microbiol 2005; 43: 1973-6.
40. Cassat JE, Lee CY, Smeltzer MS. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol Biol 2007; 391:127-44.
41. Kanaa M,Wright MJ, Sandoe JA. Examination of tunnelled haemodialysis catheters using scanning electron microscopy. Clin Microbiol Infect 2010; 16:780-6.
42. Katsuyama M, Ichikawa H, Ogawa S, Ikezawa Z. A novel method to control the balance of skin microflora. Part 1 Attack on biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci 2005; 38:197-205.
43. Akiyama H, Huh WK, Fujii K, Yamasaki O, Oono T, Iwatsuki K. Confocal laser microscopic observation of glycocalyx production by Staphylococcus aureus in vitro. J Dermatol Sci 2002; 29:54-61.
44. Akiyama H, Ueda M, Kanzaki H, Tada J, Arata J. Biofilm formation of Staphylococcus aureus strains isolated from impetigo and furuncle: role of fibrinogen and fibrin. J Dermatol Sci 1997; 16:2-10.
45. Croes S, Stobberingh EE, Stevens KN, Knetsch ML, Koole LH. Antimicrobial and anti-thrombogenic features combined in hydrophilic surface coatings for skin-penetrating catheters. Synergy of co-embedded silver particles and heparin. ACS Appl Mater Interfaces 2011; 3:2543-50.
46. Shanks RM, Sargent JL, Martinez RM, Graber ML, O'Toole GA. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006; 21:2247-55.
47. Stevens KN, Croes S, Boersma RS, et al. Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters. Biomaterials 2011; 32:1264-9.
48. Nemoto K, Hirota K, Ono T, Murakami K, Nagao D, Miyake Y. Effect of Varidase (streptokinase) on biofilm formed by Staphylococcus aureus. Chemotherapy 2000; 46:111-5.